Mauro Turrini

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Maria Carmela Piccirillo, Paolo A. Ascierto, Carlo Salvarani et al. · Journal of Translational Medicine · 2020 · 112 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Assessing Energy Expenditure in Cancer Patients: A Pilot Validation of a New Wearable Device

Emanuele Cereda, Mauro Turrini, Denis Ciapanna et al. · Journal of Parenteral and Enteral Nutrition · 2007 · 89 citations

Agriculture, Nutrition, Oncology +17

Old and new prognostic factors in acute myeloid leukemia with deranged core‐binding factor beta

Roberto Cairoli, Alessandro Beghini, Mauro Turrini et al. · American Journal of Hematology · 2013 · 40 citations · Full text

Medicine, Hematology, Oncology +16

Down-regulation of MicroRNAs 222/221 in Acute Myelogenous Leukemia with Deranged Core-Binding Factor Subunits

Matteo Brioschi, John A. Fischer, Roberto Cairoli et al. · Neoplasia · 2010 · 37 citations · Full text

Life Sciences, Genetics, Molecular Biology +17